SE425716B - PHYSIOLOGICALLY ACCEPTABLE, PARTICULAR CARRIER FOR TEKNETIUM-99M IN DIAGNOSTIC AGENTS, WHICH ESSENTLY CONSISTS OF MAINLY WATERLESSLY MODIFIED STARCH DERIVATIVE - Google Patents

PHYSIOLOGICALLY ACCEPTABLE, PARTICULAR CARRIER FOR TEKNETIUM-99M IN DIAGNOSTIC AGENTS, WHICH ESSENTLY CONSISTS OF MAINLY WATERLESSLY MODIFIED STARCH DERIVATIVE

Info

Publication number
SE425716B
SE425716B SE7607673A SE7607673A SE425716B SE 425716 B SE425716 B SE 425716B SE 7607673 A SE7607673 A SE 7607673A SE 7607673 A SE7607673 A SE 7607673A SE 425716 B SE425716 B SE 425716B
Authority
SE
Sweden
Prior art keywords
teknetium
essently
waterlessly
mainly
physiologically acceptable
Prior art date
Application number
SE7607673A
Other languages
Swedish (sv)
Other versions
SE7607673L (en
Inventor
F A Hartman
H C Kretschmar
A J Tofe
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority to SE7607673A priority Critical patent/SE425716B/en
Publication of SE7607673L publication Critical patent/SE7607673L/en
Publication of SE425716B publication Critical patent/SE425716B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1268—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
SE7607673A 1976-07-05 1976-07-05 PHYSIOLOGICALLY ACCEPTABLE, PARTICULAR CARRIER FOR TEKNETIUM-99M IN DIAGNOSTIC AGENTS, WHICH ESSENTLY CONSISTS OF MAINLY WATERLESSLY MODIFIED STARCH DERIVATIVE SE425716B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE7607673A SE425716B (en) 1976-07-05 1976-07-05 PHYSIOLOGICALLY ACCEPTABLE, PARTICULAR CARRIER FOR TEKNETIUM-99M IN DIAGNOSTIC AGENTS, WHICH ESSENTLY CONSISTS OF MAINLY WATERLESSLY MODIFIED STARCH DERIVATIVE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607673A SE425716B (en) 1976-07-05 1976-07-05 PHYSIOLOGICALLY ACCEPTABLE, PARTICULAR CARRIER FOR TEKNETIUM-99M IN DIAGNOSTIC AGENTS, WHICH ESSENTLY CONSISTS OF MAINLY WATERLESSLY MODIFIED STARCH DERIVATIVE

Publications (2)

Publication Number Publication Date
SE7607673L SE7607673L (en) 1978-01-06
SE425716B true SE425716B (en) 1982-11-01

Family

ID=20328392

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607673A SE425716B (en) 1976-07-05 1976-07-05 PHYSIOLOGICALLY ACCEPTABLE, PARTICULAR CARRIER FOR TEKNETIUM-99M IN DIAGNOSTIC AGENTS, WHICH ESSENTLY CONSISTS OF MAINLY WATERLESSLY MODIFIED STARCH DERIVATIVE

Country Status (1)

Country Link
SE (1) SE425716B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Also Published As

Publication number Publication date
SE7607673L (en) 1978-01-06

Similar Documents

Publication Publication Date Title
NO145657C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE ALKENDER DERIVATIVES.
IT1083897B (en) UREF OR TIO-UREE, PROCEDURE FOR THEIR PREPARATION AND USE AS FUNGICIDES
BE866156A (en) GUANIDINE DERIVATIVES
BE859012A (en) 4-N-ACYLFORTIMICINS B DERIVATIVES, THEIR PREPARATION AND APPLICATION
IT7825315A0 (en) SUBSTITUTED PHENOXY-BENZYL-OXICARBONIL DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES AND AS ACARICIDES.
NL7810563A (en) IMIDAZOLIDINE DERIVATIVES.
NL7707646A (en) POLYGALACTOSIDOSUCROSED DERIVATIVES WITH COMPLETE-INHIBITING ACTIVITY.
SE431653B (en) PROCEDURE FOR PREPARING 2,3-DIHYDRO-IMIDAZO / 2,1-B / TIAZOLD DERIVATIVES
NO802015L (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE INDOLIZIN DERIVATIVES.
RO71931A (en) PROCEDURE FOR THE PREPARATION OF 3,4-DIHYDRO-2H-IZOCHINOLIN-1-ONE OR 1,2,3,4-TETRAHYDRO-5H-BENZAZEPINE-1-ONE PHENYLTILAMINE DERIVATIVES
AR224095A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF DITIOL-1,2 TIONA-3
FR2303016A1 (en) (1,5-A) (1,4) -DIAZEPINE DERIVATIVES
NO820290L (en) INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF THERAPEUTIC ACTIVE ANTHRAKINONE DERIVATIVES.
SE7808059L (en) PROCEDURE FOR PREPARING 1,2,4-TRIAZIN-5-ON DERIVATIVES
NL7801005A (en) DERIVATIVES OF META-SULFONAMIDO-BENZAMIDE.
NO149428C (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND INGREDIATES.
NO151365C (en) PROCEDURE FOR THE PREPARATION OF 4-HALOGEN-DIHYDROPYRANE DERIVATIVES.
NL7804550A (en) METHOD OF PREPARATION OF UREA DERIVATIVES.
MC1192A1 (en) BENZIMIDAZOLE DERIVATIVES
SE439631B (en) PROCEDURE FOR PREPARING 3,4-DIHYDROCARBOSTYRYL DERIVATIVES
BE857576A (en) PHENOTHIAZINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
NO147423C (en) PROCEDURE FOR PREPARING 2-PIPERAZINYL-CHINAZOLINE DERIVATIVES.
SE425716B (en) PHYSIOLOGICALLY ACCEPTABLE, PARTICULAR CARRIER FOR TEKNETIUM-99M IN DIAGNOSTIC AGENTS, WHICH ESSENTLY CONSISTS OF MAINLY WATERLESSLY MODIFIED STARCH DERIVATIVE
BE868881A (en) ALPHA-HALOGENOMETHYL-AMINO-ACIDS AND THEIR DERIVATIVES, THEIR PREPARATION AND THEIR USE
IT1096161B (en) DIMERIC INDOLO-DIHYDROINDOLE, USEFUL AS ANTI-TUMORAL AGENT